Sequential drug delivery to modulate macrophage behavior and enhance implant integration
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Macrophages are major upstream regulators of the inflammatory response to implanted biomaterials. Sequential functions of distinct macrophage phenotypes are essential to the normal tissue repair process, which ideally results in vascularization and integration of implants. Improper timing of M1 or M2 macrophage activation results in dysfunctional healing in the form of chronic inflammation or fibrous encapsulation of the implant. Thus, biphasic drug delivery systems that modulate macrophage behavior are an appealing approach to promoting implant integration. In this review, we describe the timing and roles of macrophage phenotypes in healing, then highlight current drug delivery systems designed to sequentially modulate macrophage behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 2×
“M2 macrophages are polarized via the cytokines IL-4 and IL-13 (M2a) [19], or IL10 (M2c) [20].”
BackgroundArnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070075 · Cited by 2,002
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960
The many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902 · cited 3×
“For instance, it has been posited that the complete activation of M1 macrophages requires not only IFNγ, but also TNFα or a Toll-like receptor ligand such as LPS [108].”
BackgroundDifferential Roles of Macrophages in Diverse Phases of Skin Repair
Lucas, T., Waisman, A., Ranjan, R., Roes, J., Krieg, T., Müller, W., Roers, A., & Eming, S. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903356 · Cited by 1,205 · cited 2×
“found that in murine wounds, macrophages are necessary for the early inflammatory phase and the secondary tissue formation phase, each of which lasts for a few days, but are less important in the final stage involving tissue maturation [46].”
BackgroundSindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44490 · Cited by 1,100 · cited 3×
“The initial stage is marked by the presence of mostly pro-inflammatory macrophages [4, 5], but lasts for only a short time before giving way to the next phase, in which macrophages with a distinct and noninflammatory phenotype dominate [6].”
BackgroundThe role of macrophage phenotype in vascularization of tissue engineering scaffolds
Spiller, K. L., Anfang, R. R., Spiller, K. J., Ng, J., Nakazawa, K. R., Daulton, J. W., & Vunjak-Novakovic, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.012 · Cited by 948
Self-citationLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Macrophage activation switching: an asset for the resolution of inflammation
Porcheray, F., Viaud, S., Rimaniol, A.-C., Léone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., & Gras, G. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02934.x · Cited by 840 · cited 1×
“Although it has been suggested that the latter phenotype is recruited to the site of injury [7], a growing body of evidence shows that proinflammatory macrophages are able to repolarize into this less-inflammatory population, suggesting a potential for in situ transition [8-10].”
BackgroundSpiller, K. L., Nassiri, S., Witherel, C. E., Anfang, R. R., Ng, J., Nakazawa, K. R., Yu, T., & Vunjak-Novakovic, G. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.017 · Cited by 773
Self-citation
Cited by
Martin, K. E., & García, A. J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.038 · Cited by 367
Immunomodulatory Biomaterials for Tissue Repair
Whitaker, R., Hernaez-Estrada, B., Hernandez, R. M., Santos-Vizcaino, E., & Spiller, K. L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00895 · Cited by 338
Self-citationRegulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages
Witherel, C. E., Sao, K., Brisson, B. K., Han, B., Volk, S. W., Petrie, R. J., Han, L., & Spiller, K. L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120667 · Cited by 212
Self-citationZhou, H., He, Z., Cao, Y., Chu, L., Liang, B., Yu, K., & Deng, Z. (2024) · Theranostics · doi:10.7150/thno.97412 · Cited by 115
Ye, J., Xie, C., Wang, C., Huang, J., Yin, Z., Heng, B. C., Chen, X., & Shen, W. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.017 · Cited by 97
Metadata
- Authors
- O'Brien, E. M., Risser, G. E., & Spiller, K. L.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 149-150
- Pages
- 85-94
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2945786100
- Cited by
- 124
- References
- 25
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sequential drug delivery to modulate macrophage behavior and enhance implant integration. https://app.cochat.ai/papers/10.1016/j.addr.2019.05.005
- The paper
- O'Brien, E. M., Risser, G. E., & Spiller, K. L. (2019). Sequential drug delivery to modulate macrophage behavior and enhance implant integration. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2019.05.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.